EATRIS, the European infrastructure for translational medicine, as part of the EU-funded PRECISEU project. is leading a groundbreaking effort to map Advanced Therapy Medicinal Product (ATMP) capacities across Europe. This strategic initiative is designed to strengthen Europe’s preparedness and infrastructure for delivering cutting-edge therapies, ensuring that patients across all regions have equitable access to life-saving innovations in ATMPs.
ATMPs, which include gene therapies, cell-based treatments, and tissue-engineered products, represent one of the most promising frontiers in medicine. Yet, despite major advances in research and clinical development, the ability of health systems to deliver these therapies varies widely across the continent. Identifying and understanding these disparities is a critical step in building a more coordinated and efficient European ATMP ecosystem.
A Data-Driven Approach to Transformative Medicine
This PRECISEU mapping exercise focuses on assessing the capabilities of:
- Academic and translational research centers
- GMP manufacturing and processing facilities
- Clinical trial sites and hospitals
- National regulatory frameworks and logistics infrastructure
By capturing this data, the initiative will provide a clear, actionable overview of where ATMP development and delivery are strongest and where additional support is needed.
Enabling Smarter Collaboration and Investment
The outcomes of this mapping initiative will inform:
- Policy and investment decisions at both national and EU levels
- Capacity building in under-served regions
- Efficient referral pathways for patients needing specialized care
- Strategic site selection for clinical trials and manufacturing
- Stronger Public-Private partnerships across the value chain
It will also facilitate cross-border collaboration, supporting the alignment of clinical, regulatory, and logistical efforts to reduce delays and duplication. By doing so, the project advances the core goals of PRECISEU: to operationalise precision medicine through harmonised, patient-centred innovation.
Through the work and commitment of the PRECISEU partners and with thanks to the EMA for the for their valuable contribution to improve this survey’s focus and granularity, we hope this critical mapping of ATMP development capacities will serve not only as a snapshot of current capacities, but also as a strategic tool for long-term development driving future planning, funding, and international competitiveness in the ATMP space.
- Find out more about the survey here: https://eatris.eu/news/eatris-leads-strategic-mapping-of-atmp-capacities-across-europe-through-preciseu/
- For additional info reach out to Dr David Morrow at davidmorrow@eatris.eu